Company / Cash per Share
Intellia Therapeutics, Inc. Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.52
FY2025
5-year range
$1.52 / $7.03
FY2021-FY2025
Trend
-25.1%
vs FY2024
Sector context
#99 of 150
Health Care
What the data says
At $1.52, Intellia Therapeutics, Inc.'s cash per share ranks #99 of 150 in the Health Care sector. Cash per Share has declined for 3 consecutive years, from $7.03 in FY2022 to $1.52 in FY2025.
Based on SEC 10-K filings.
1.52 in FY2025 with a 5-year CAGR of -13.7%.
Declined from $2.60 to $1.52 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -39.9%
- 5-Year CAGR
- -13.7%
- 10-Year CAGR
- -
Sector benchmark
#99 of 150 in Health CareTop 66% of 150This company $1.52 Sector average $27.04
▼
-94.4% below sector average
Key checks
Key Insights
- Intellia Therapeutics, Inc.'s cash per share has declined for 3 consecutive years.
- In FY2025, cash per share decreased 25.1% year-over-year.
- Ranks #99 out of 150 companies in the Health Care sector.
- Peak cash per share was recorded in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.14 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.52 | -25.1% |
| FY2024 | $2.03 | -21.9% |
| FY2023 | $2.60 | -63.0% |
| FY2022 | $7.03 | +277.2% |
| FY2021 | $1.86 | -41.6% |
| FY2020 | $3.19 | +151.9% |
| FY2019 | $1.27 | -8.9% |
| FY2018 | $1.39 | -85.3% |
| FY2017 | $9.46 | -23.0% |
| FY2016 | $12.29 | -96.1% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026